Large-scale testing (Phase 3)Study completedNCT00089661
What this trial is testing
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Who this might be right for
Breast CancerLow Bone Mineral DensityOsteopenia
Amgen 252